跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROCTAVIAN 2 × 10E13 GENOMAS DE VECTOR/ML SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ROCTAVIAN 2 × 10E13 GENOMAS DE VECTOR/ML SOLUCION PARA PERFUSION
Approved
STANDARD
ROCTAVIAN 2 × 10E13 GENOMAS DE VECTOR/ML SOLUCION PARA PERFUSION
Biomarin International Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 3, 2023
Approval ID
97a9e39fe7a2c78b
Company
Biomarin International Limited
Type
Standard
Approval Details
Approval Id
97a9e39fe7a2c78b
Drug Cima Aemps Name
ROCTAVIAN 2 × 10E13 GENOMAS DE VECTOR/ML SOLUCION PARA PERFUSION
Register Number
1221668001
Holder Company Name
Biomarin International Limited
Marketing Company Name
Biomarin Pharmaceuticals España S.L.
Holder Company Detail Path
/organization/biomarin-international-limited
Authorization Date
2023-02-03
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
2 × 10E13 VG/ML
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Biomarin International Limited
Company Detail Path
/organization/biomarin-international-limited
Company Information
Pharmaceutical Company Name
Biomarin International Limited
Country Name
Australia
Active Ingredients
VALOCTOCOGEN ROXAPARVOVEC
2x10E13 vg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 3, 2023
Approval ID
97a9e39fe7a2c78b
Type
Standard
Back to CIMA-AEMPS Approvals